
Utilizing precision medicine has the potential to improve outcomes in many diseases. However, the effect of precision medicine in prescribing glucose-lowering medications in type 2 diabetes mellitus (T2DM) had not been tested. Two new studies present the findings of the Tri Master clinical trial, which investigated the effect of personalizing glucose-lowering medications in T2DM.
Like
Save
Share